Eliminating Undernutrition Could Avert Up To 2.3 Million TB Cases Globally, Lancet Study Finds

IMT News Desk
IMT News Desk
· 2 min read
Eliminating undernutrition could prevent up to 2.3 million TB cases globally

Addressing undernutrition could prevent nearly one in four adult tuberculosis (TB) cases worldwide, with India projected to gain the most if nutrition gaps are closed, according to a new modelling analysis published in The Lancet Global Health. The study estimates that eliminating all forms of undernutrition could avert 2.3 million TB episodes globally, representing a 23.7 per cent reduction in adult TB incidence in 2023. Researchers found that India, followed by Indonesia, the Philippines and Pakistan, would see the largest absolute declines in TB burden if undernutrition is effectively tackled.

The authors modelled different scenarios and reported that even a more modest target, eliminating moderate-to-severe undernutrition, could avert 1.4 million TB cases, corresponding to a 14.6 per cent reduction in global adult TB incidence. The findings reinforce growing evidence that undernutrition is not just a background social determinant, but a primary driver of TB risk in many high-burden countries, where large sections of the population live with low body mass index and food insecurity.

The study’s estimates come at a critical time for TB programmes that are struggling to meet End TB Strategy milestones, particularly after setbacks during the Covid-19 pandemic. While global efforts have historically prioritised diagnostics, drugs and vaccines, the new analysis suggests that nutrition-focused interventions could yield substantial epidemiological gains at the population level, complementing biomedical tools.

For India, where undernutrition has been identified as the single largest risk factor for developing active TB, the results provide quantitative backing for integrating nutrition more centrally into the National Tuberculosis Elimination Programme. Previous modelling from India has shown that reducing undernutrition in vulnerable states could cut TB incidence and mortality by more than 40 per cent over two decades, underscoring the potential of food and income support schemes to shift the trajectory of the epidemic.

Experts say the Lancet Global Health analysis adds urgency to calls for sustained investments in social protection, dietary support and poverty alleviation as part of TB control strategies, rather than viewing them as peripheral add-ons. They argue that without systematic action on undernutrition, high-burden countries are unlikely to achieve the steep annual declines in TB incidence needed to meet global targets, even if diagnostics and treatment coverage continue to expand.

Read Next

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules
News
June 11, 2026

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules

Alembic Pharmaceuticals Limited (Alembic) announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Larotrectinib Capsules, 25 mg and 100 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Vitrakvi Capsules, 25 mg and 100 mg, of […]
Article by: IMT News Desk
DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability performance 
News
June 11, 2026

DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability performance 

DFE Pharma has earned its third consecutive Gold Medal from EcoVadis, the world leader in corporate sustainability assessments, in recognition of its strong performance in the four themes rated: Environment, Labor & Human Rights, Ethics and Sustainable Procurement. This distinction places DFE Pharma in the top 5% of companies, reflecting the company’s focused efforts to […]
Article by: IMT News Desk
Oval Fertility Inks MoU with Merck to Advance Reproductive Care Standards in India
News
June 11, 2026

Oval Fertility Inks MoU with Merck to Advance Reproductive Care Standards in India

Oval Advanced Fertility Care and Merck Specialities Private Limited, the Indian healthcare arm of Merck KGaA, Darmstadt, Germany and a global leader in fertility sciences with decades of scientific leadership in reproductive medicine, have signed a strategic Memorandum of Understanding (MOU).   India’s IVF market, valued at approximately USD 2.35 billion in 2024, is projected […]
Article by: IMT News Desk
Infosys-backed 4baseCare raises ₹128 crore, plans to take its cancer testing platform global
News
June 11, 2026

Infosys-backed 4baseCare raises ₹128 crore, plans to take its cancer testing platform global

Bengaluru-based precision oncology startup 4baseCare has raised ₹128 crore in its ongoing Series B funding round to expand its hospital-linked genomics laboratory network globally and scale its AI-powered precision oncology platform, OncoTwin. The latest funding round, which follows a first close of ₹90 crore co-led by Ashish Kacholia and Lashit Sanghvi with participation from existing […]
Article by: IMT News Desk